Company intelligence / Profile preview

Andall Biosciences

Ontario, California, United States

Ownership: Private
Development stage: Other

Overview

Andall Biosciences' primary product line (23WELL Ovary Care Capsule) has FDA Certificate of Free Sale, patent applications in multiple countries, and is being sold in Asia and North America. Products are produced in a Class 100,000 GMP Cleanroom facility. No clinical trial or IND-stage results were cited; products are marketed as health supplements

Therapeutic areas: GastroenterologyWomen's HealthNeurologyOther
Modalities: Small moleculePeptidesExtract-based nutritionalsNutritional supplement/Device
Industry: Food & Nutrition

Partnerships

Circle Harmony (medical service institution in Shanghai)collaboration with TikTok influencers for brand promotion

Beyond the preview

Go deeper on Andall Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Andall Biosciences.

Explore the full profile